Atrial flutter is a cardiac rhythm disorder characterized by rapid, coordinated contractions of the atria, the heart's upper chambers. Unlike atrial fibrillation, atrial flutter involves a well-organized and regular circuit of electrical signals in the heart. This abnormal rhythm can result from various factors, including heart disease, surgery, or lung conditions. Individuals with atrial flutter may experience symptoms such as a fluttering sensation in the chest, dizziness, or fainting. While atrial flutter is typically not immediately life-threatening, it can lead to complications such as blood clots and stroke. Diagnosis involves an electrocardiogram (ECG), and management may include medications to control heart rate and rhythm, as well as procedures like catheter ablation to correct the irregular electrical pathways. Early detection and appropriate intervention are essential in addressing atrial flutter and preventing potential complications.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt